While the infant formula segment is driving toward premiumization, fierce competition continues, especially in China, which has accounted for almost half of the global market size. Can probiotics help boost market growth? Explore the opportunities of the well-studied human-residential Bifidobacterium (HRB) strain - Bifidobacterium longum BB536 for use in infant formula.
This Technical Paper is from Morinaga Milk.

READ THIS NEXT: Iron and Celiac Disease



Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Texture challenges in high protein bars: Understanding the benefits of casein
Lactalis Ingredients













